Centocor President Neal Fowler: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Exec discusses the anti-TNF market and the entry of Abbott’s Humira – the first competitor for Remicade – in Crohn’s disease.